Quarterly report pursuant to Section 13 or 15(d)

REVENUES

v3.20.2
REVENUES
 9 Months Ended
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]  
REVENUES

NOTE 15 – REVENUES

 

The Company’s revenues were comprised of the following major categories:

 

SCHEDULE OF REVENUES COMPRISED OF MAJOR CATEGORIES 

    Nine Months Ended September 30,  
    2020     2019  

Product sales

    

21,992,298

      

60,839

  

Product sales from related party

    

 -

      

29,029,249

  
Real estate   $ 5,065,538     $ 5,250,084  
Management     1,081,562       1,963,205  
Supply procurement     1,218,334       2,830,555  
Licensing     1,179,113       1,230,366  
Other     984       47,893  
Total revenues   $ 30,537,829     $ 40,412,191  

 

The amount under Product Sales From Related Party shown in the table above represents the total revenues from the seed transactions with GenCanna, which is further disclosed in Note 17 – Related Party Transactions. Excluding these revenues, for the nine months ended September 30, 2020 and 2019, revenue from two clients represented 24% and 82%, respectively, of total revenues.